Analyst Steve Chesney works at ATLANTIC EQUITIES and is covering the the Healthcare sector with 73 price targets and ratings documented since 2015 spanning on 8 stocks.
Steve Chesney's average stock forecast success ratio is 66.13% with an average time for price targets to be met of 364.5 days.
Most recent stock forecast was given on JNJ, Johnson & Johnson at 19-Apr-2023.
Analyst best performing recommendations are on IDXX (IDEXX LABORATORIES, INC).
The best stock recommendation documented was for JNJ (JOHNSON & JOHNSON) at 7/21/2017. The price target of $113 was fulfilled within 5 days with a profit of $3.25 (2.8%) receiving and performance score of 5.59.
Average potential price target upside
Currently, out of the existing stock ratings of Steve Chesney - 1 which are a Hold (16.67%), 5 which are a Buy (83.33%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
340
$37.87 (12.53%)
350
4 days ago
35/45 (77.78%)
$28.45 (10.91%)
150
Buy
360
$57.87 (19.15%)
346
5 days ago
37/49 (75.51%)
$56 (19.33%)
464
Hold
263
$-39.13 (-12.95%)
263
14 days ago
8/14 (57.14%)
$-26.94 (-9.93%)
119
Buy
350
$47.87 (15.84%)
320
26 days ago
0/2 (0%)
$33.62 (11.11%)
Buy
325
$22.87 (7.57%)
325
1 months 26 days ago
5/13 (38.46%)
$68.69 (26.96%)
224
